Topics, Trends & Updates

October 2023

View as web page

Facebook  Twitter  Linkedin  Instagram  

New Guideline: Doxy-PEP

to Prevent Bacterial STIs

Lead authors Drs. Daniela DiMarco and Marguerite Urban, with the NYSDOH AI Medical Care Criteria Committee, developed this guideline on the use of doxycycline post-exposure prophylaxis (doxy-PEP) for prevention of bacterial sexually transmitted infections (STIs).

The purpose of this guideline is to support clinicians providing care for adults and adolescents with and without HIV who are at risk of acquiring bacterial STIs through sexual exposure.

The goals of this guideline are to:

  • Summarize the available evidence regarding the use of doxy-PEP for preventing syphilis, chlamydia, and gonorrhea infections
  • Provide evidence-based clinical recommendations for the use of doxy-PEP
  • Present practical considerations for prescribing doxy-PEP

Read the full guideline now


Related Guidelines:

Updated Guideline: Treatment

of Alcohol Use Disorder

Lead author Dr. Yonina Mar, with the NYSDOH AI Substance Use Guidelines Committee, developed this guideline on the treatment of alcohol use disorder (AUD) to support clinical practitioners who provide medical care for adults in New York State.

The purpose of this guideline is to:

  • Increase clinicians’ awareness of the risks associated with AUD of any severity and the benefits of diagnosing and treating AUD in adults
  • Increase clinicians’ knowledge of available evidence-based treatments for AUD and withdrawal management and increase the availability of AUD treatment in ambulatory care settings in New York State
  • Promote a harm reduction approach to AUD treatment through implementation of practical strategies for reducing the negative consequences associated with alcohol use

Primary care clinicians in New York State can play an essential role in identifying and treating unhealthy alcohol use and AUD in their patients.

Read the full guideline now


Related Guidelines:

New: Questions, Answers, and Best Practices for Medical Management of Perinatal HIV Exposure in NYS

This guidance, presented in a Q/A format, is for clinicians in NYS who provide medical care for newborns and infants with perinatal HIV exposure. With 2 exceptions, the NYSDOH AI supports the DHHS recommendations for Diagnosis of HIV Infection in Infants and Children. Points of difference are that the NYSDOH AI strongly advises clinicians to:

  1. Perform at-birth testing of all exposed infants, regardless of the assessed risk of HIV acquisition (DHHS recommends birth testing for high-risk exposures only) and
  2. Recognize fewer than 3 prenatal care visits as a criterion for high-risk exposure (DHHS considers 0 prenatal care visits high risk).

Read the full guidance now

PrEP Aware Week Webinars From CEI

Hot Topics

See all Hot Topics

Conversations With CEI Podcast

Patients with HIV are known to have up to a two-fold increase in heart-related events, compared with the general population. Could treatment with statins reduce this risk?

Dr. Steven Fine, an infectious disease specialist affiliated with the University of Rochester, reviews the recently published results of the REPRIEVE trial. The big picture is a 35% reduction in heart-related events. Dr. Fine digs into the details and statistics of the trial, and the encouraging results of statin treatment, even in those deemed to be at lower risk.

Listen Now

Upcoming Training, Education, and Events


See all


See all

Are You a Subscriber?

If this newsletter was forwarded to you, please subscribe now to make sure you receive the Clinical Guidelines Program Topics, Trends, and Updates newsletter every month and stay current with new and updated guidelines. We send 1 email per month and do not share our mailing list.

Comments? Questions? Suggestions?

Email us: [email protected]. 

We'll get back to you as quickly as possible.

Note that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice.